Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neurol Neurosurg Psychiatry ; 90(2): 187-194, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30196252

RESUMO

OBJECTIVE: X linked Charcot-Marie-Tooth disease (CMTX) is a hereditary neuropathy caused by mutations in GJB1 coding for connexin-32, a gap junction protein expressed in Schwann cells, but also found in oligodendrocytes. Four patients with CMTX developing central nervous system (CNS) demyelination compatible with multiple sclerosis (MS) have been individually published. We presently sought to systematically investigate the relationship between CMTX and MS. METHODS: Over 20 years, 70 consecutive patients (36 men) with GJB1 mutations were identified at our Neurogenetics Unit, Athens, Greece, and assessed for clinical features suggestive of MS. Additionally, 18 patients with CMTX without CNS symptoms and 18 matched controls underwent brain MRI to investigate incidental findings. Serum from patients with CMTX and MS was tested for CNS immunoreactivity. RESULTS: We identified three patients with CMTX who developed clinical features suggestive of inflammatory CNS demyelination fulfilling MS diagnostic criteria. The resulting 20-year MS incidence (4.3%) differed significantly from the highest background 20-year MS incidence ever reported from Greece (p=0.00039). The search for incidental brain MRI findings identified two CMTX cases (11%) with lesions suggestive of focal demyelination compared with 0 control. Moreover, 10 cases in the CMTX cohort had hyperintensity in the splenium of the corpus callosum compared with 0 control (p=0.0002). No specific CNS-reactive humoral factors were identified in patients with CMTX and MS. CONCLUSIONS: We have demonstrated a higher than expected frequency of MS in patients with CMTX and identified incidental focal demyelinating lesions on brain MRI in patients with CMTX without CNS symptoms. This provides circumstantial evidence for GJB1 mutations acting as a possible MS risk factor.


Assuntos
Doença de Charcot-Marie-Tooth/complicações , Esclerose Múltipla/epidemiologia , Adulto , Idoso , Estudos de Casos e Controles , Doença de Charcot-Marie-Tooth/diagnóstico por imagem , Doença de Charcot-Marie-Tooth/genética , Estudos de Coortes , Conexinas/genética , Feminino , Grécia , Humanos , Incidência , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla/diagnóstico , Esclerose Múltipla/genética , Mutação , Adulto Jovem , Proteína beta-1 de Junções Comunicantes
2.
Mult Scler Relat Disord ; 13: 112-115, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28427691

RESUMO

BACKGROUND: Spastic paretic hemifacial contracture (SPHC) is characterized by sustained unilateral contraction of the facial muscles associated with mild ipsilateral facial paresis. Rarely described in the context of multiple sclerosis (MS), it has never been reported as presenting symptom of MS. CASE REPORTS: Two patients developed SPHC within the context of a clinically isolated syndrome suggestive of MS. EMG revealed continuous resting activity of irregularly firing motor unit potentials, associated with impaired recruitment upon voluntary contraction. SPHC remitted fully in both patients. CONCLUSIONS: SPHC, a rare but distinct clinical and EMG entity, can occasionally be the presenting feature of MS.


Assuntos
Contratura/diagnóstico , Músculos Faciais/fisiopatologia , Paralisia Facial/diagnóstico , Esclerose Múltipla/diagnóstico , Espasticidade Muscular/diagnóstico , Adulto , Encéfalo/diagnóstico por imagem , Encéfalo/patologia , Contratura/complicações , Eletromiografia , Paralisia Facial/complicações , Feminino , Humanos , Masculino , Esclerose Múltipla/complicações , Esclerose Múltipla/patologia , Espasticidade Muscular/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...